Cash Flow Stocks Draw Attention Amid European Rate Hike Concerns

Cash flow stocks are gaining attention from investors looking for reliable returns in uncertain times. Central banks in Europe may raise interest rates to combat inflation, which could further pressure equity valuations.

With this uncertainty in mind, three Australian companies with strong cash flow potential and undervalued stock prices stand out: Mesoblast (ASX:MSB), Telix Pharmaceuticals (ASX:TLX), and WiseTech Global (ASX:WTC).

Mesoblast, a Melbourne-based biotechnology company, is developing late-stage cell therapies for severe inflammatory and cardiovascular diseases. If commercialized successfully, these programs could support substantial future cash flows.